Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 236

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine

Open access
Bruni, Natascia, Capucchio, Maria, Biasibetti, Elena, Pessione, Enrica, Cirrincione, Simona, Giraudo, Leonardo, Corona, Antonio, Dosio, Franco · 2016 · Molecules

Abstract

Antimicrobial peptides (AMPs) represent a vast array of molecules produced by virtually all living organisms as natural barriers against infection. Among AMP sources, an interesting class regards the food-derived bioactive agents. The whey protein lactoferrin (Lf) is an iron-binding glycoprotein that plays a significant role in the innate immune system, and is considered as an important host defense molecule. In search for novel antimicrobial agents, Lf offers a new source with potential pharmaceutical applications. The Lf-derived peptides Lf(1–11), lactoferricin (Lfcin) and lactoferrampin exhibit interesting and more potent antimicrobial actions than intact protein. Particularly, Lfcin has demonstrated strong antibacterial, anti-fungal and antiparasitic activity with promising applications both in human and veterinary diseases (from ocular infections to osteo-articular, gastrointestinal and dermatological diseases).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules21060752

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 123

  1. Reddy, 2004, Antimicrobial peptides: Premises and promises, Int. J. Antimicrob. Agents, 24, 536, 10.1016/j.ijantimicag.2004.09.005 · DOI · Paper page
  2. Tam, 2015, Antimicrobial peptides from plants, Pharmaceuticals, 8, 711, 10.3390/ph8040711 · DOI · Paper page
  3. Hancock, 2006, Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies, Nat. Biotechnol., 24, 1551, 10.1038/nbt1267 · DOI · Paper page
  4. Jenssen, 2006, Peptide antimicrobial agents, Clin. Microbiol. Rev., 19, 491, 10.1128/CMR.00056-05 · DOI · Paper page
  5. Wang, 2009, APD2: The updated antimicrobial peptide database and its application in peptide design, Nucleic Acids Res., 37, D933, 10.1093/nar/gkn823 · DOI · Paper page
  6. Gill, 2015, Antibiotic adjuvants: Diverse strategies for controlling drug-resistant pathogens, Chem. Biol. Drug Des., 85, 56, 10.1111/cbdd.12478 · DOI · Paper page
  7. Anuforom, 2015, The immune response and antibacterial therapy, Med. Microbiol. Immunol., 204, 151, 10.1007/s00430-014-0355-0 · DOI
  8. Korhonen, 2003, Food-derived bioactive peptides—Opportunities for designing future foods, Curr. Pharm. Des., 9, 1297, 10.2174/1381612033454892 · DOI · Paper page
  9. Atanasova, 2014, Proteolytic and antimicrobial activity of lactic acid bacteria grown in goat milk, Biotechnol. Biotechnol. Equip., 28, 1073, 10.1080/13102818.2014.971487 · DOI · Paper page
  10. Nongonierma, 2015, Bioactive properties of milk proteins in humans: A review, Peptides, 73, 20, 10.1016/j.peptides.2015.08.009 · DOI
  11. Ng, 2015, Antiviral activities of whey proteins, Appl. Microbiol. Biotechnol., 99, 6997, 10.1007/s00253-015-6818-4 · DOI
  12. Fliss, 2014, Antimicrobial peptides of dairy proteins: From fundamental to applications, Food Rev. Int., 30, 134, 10.1080/87559129.2014.896017 · DOI
  13. Fliss, 2014, MilkAMP: A comprehensive database of antimicrobial peptides of dairy origin, Dairy Sci. Technol., 94, 181, 10.1007/s13594-013-0153-2 · DOI
  14. Andersen, 2003, Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir, Antivir. Res., 58, 209, 10.1016/S0166-3542(02)00214-0 · DOI
  15. Shestakov, 2012, Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice, Antivir. Res., 93, 340, 10.1016/j.antiviral.2012.01.003 · doi:10.1016/j.antiviral.2012.01.003
  16. Mistry, 2007, The anti-papillomavirus activity of human and bovine lactoferricin, Antivir. Res., 75, 258, 10.1016/j.antiviral.2007.03.012 · DOI
  17. Omata, 2001, Reduction of the Infectivity of Toxoplasma gondii and Eimeria stiedai Sporozoites by Treatment with Bovine Lactoferricin, J. Vet. Med. Sci., 63, 187, 10.1292/jvms.63.187 · DOI
  18. Zhang, 2014, Anticancer effects of lactoferrin: Underlying mechanisms and future trends in cancer therapy, Nutr. Rev., 72, 763, 10.1111/nure.12155 · DOI
  19. Riedl, 2014, Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine, BioMetals, 27, 981, 10.1007/s10534-014-9749-0 · doi:10.1007/s10534-014-9749-0
  20. Kim, 2013, Lactoferricin mediates anti-inflammatory and anti-catabolic effects via inhibition of IL-1 and LPS activity in the intervertebral disc, J. Cell. Physiol., 228, 1884, 10.1002/jcp.24350 · DOI
  21. Embleton, 2013, Lactoferrin: Antimicrobial activity and therapeutic potential, Semin. Fetal Neonat. Med., 18, 143, 10.1016/j.siny.2013.02.001 · DOI
  22. Leboffe, 2009, Antifungal and antiparasitic activities of lactoferrin, Anti-Infect. Agents Med. Chem., 8, 114, 10.2174/187152109787846105 · DOI
  23. 2014, Immunomodulatory effects of lactoferrin, Acta Pharmacol. Sin., 35, 557, 10.1038/aps.2013.200 · DOI · Paper page
  24. Kanwar, 2015, Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions, Molecules, 20, 9703, 10.3390/molecules20069703 · DOI
  25. Brock, 2012, Lactoferrin-50 years on, Biochem. Cell Biol., 90, 245, 10.1139/o2012-018 · DOI
  26. Arnold, 1980, Bactericidal activity of human lactoferrin: Sensitivity of a variety of microorganisms, Infect. Immun., 28, 893, 10.1128/iai.28.3.893-898.1980 · DOI · Paper page
  27. Ochoa, 2012, Clinical studies of lactoferrin in children, Biochem. Cell Biol., 90, 457, 10.1139/o11-087 · DOI
  28. Sharma, 2016, Lactoferrin and neonatology-role in neonatal sepsis and necrotizing enterocolitis: Present, past and future, J. Mater. Fetal Neonat. Med., 29, 763, 10.3109/14767058.2015.1017463 · DOI
  29. Ochoa, 2008, Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children, Clin. Infect. Dis., 46, 1881, 10.1086/588476 · DOI
  30. Masci, 2000, Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme, AIDS, 14, 2403, 10.1097/00002030-200010200-00023 · DOI
  31. 2008, Evaluation of the clinical efficacy of a mouthwash and oral gel containing the antimicrobial proteins lactoperoxidase, lysozyme and lactoferrin in elderly patients with dry mouth—A pilot study, Gerodontology, 25, 3, 10.1111/j.1741-2358.2007.00197.x · doi:10.1111/j.1741-2358.2007.00197.x
  32. Kuipers, 2002, Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis, Drug Deliv., 9, 31, 10.1080/107175402753413154 · DOI · Paper page
  33. Wakabayashi, 2009, Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia, Antimicrob. Agents Chemother., 53, 3308, 10.1128/AAC.01688-08 · DOI
  34. Planas, 1999, Effects of topical application of free and liposome-encapsulated lactoferrin and lactoperoxidase on oral microbiota and dental caries in rats, Arch. Oral Biol., 44, 901, 10.1016/S0003-9969(99)00092-8 · doi:10.1016/s0003-9969(99)00092-8
  35. Yadav, 2014, Effect of periodontal therapy on lactoferrin levels in gingival crevicular fluid, Aust. Dent. J., 59, 314, 10.1111/adj.12203 · DOI
  36. Sachdeva, 2014, Efficacy of fermented milk and whey proteins in helicobacter pylori eradication: A review, World J. Gastroenterol., 20, 724, 10.3748/wjg.v20.i3.724 · DOI
  37. Dial, 1998, Antibiotic properties of bovine lactoferrin on Helicobacter pylori, Dig. Dis. Sci., 43, 2750, 10.1023/A:1026675916421 · DOI
  38. Vitetta, 2013, The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: A double blind randomized study, Complement. Ther. Med., 21, 164, 10.1016/j.ctim.2012.12.006 · DOI
  39. Leonardi, 2007, Helicobacter pylori eradication: A randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics, Am. J. Gastroenterol., 102, 951, 10.1111/j.1572-0241.2007.01085.x · DOI
  40. Nappi, 2009, Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: A prospective controlled randomized study, Acta Obstet. Gynecol. Scand., 88, 1031, 10.1080/00016340903117994 · DOI
  41. Manzoni, 2009, Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: A randomized trial, JAMA J. Am. Med. Assoc., 302, 1421, 10.1001/jama.2009.1403 · DOI · Paper page
  42. Sinha, M., Kaushik, S., Kaur, P., Sharma, S., and Singh, T.P. (2013). Antimicrobial Lactoferrin Peptides: The Hidden Players in the Protective Function of a Multifunctional Protein. Int. J. Pept., 2013. · DOI
  43. Ulvatne, 2004, Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis, FEMS Microbiol. Lett., 237, 377
  44. Lupetti, 2000, Candidacidal activities of human lactoferrin peptides derived from the N terminus, Antimicrob. Agents Chemother., 44, 3257, 10.1128/AAC.44.12.3257-3263.2000 · DOI
  45. Lupetti, 2002, Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin, Antimicrob. Agents Chemother., 46, 1634, 10.1128/AAC.46.6.1634-1639.2002 · DOI
  46. Lupetti, 2003, Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species, Antimicrob. Agents Chemother., 47, 262, 10.1128/AAC.47.1.262-267.2003 · DOI
  47. Nibbering, 2001, Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria, Infect. Immun., 69, 1469, 10.1128/IAI.69.3.1469-1476.2001 · DOI · Paper page
  48. Stallmann, 2003, Continuous-release or burst-release of the antimicrobial peptide human lactoferrin 1–11 (hLF1–11) from calcium phosphate bone substitutes, J. Antimicrob. Chemother., 52, 853, 10.1093/jac/dkg443 · doi:10.1093/jac/dkg443
  49. Stallmann, 2004, Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1–11-or gentamicin-containing calcium phosphate cement, J. Antimicrob. Chemother., 54, 472, 10.1093/jac/dkh346 · DOI
  50. Faber, 2005, Comparable efficacies of the antimicrobial peptide human lactoferrin 1–11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model, Antimicrob. Agents Chemother., 49, 2438, 10.1128/AAC.49.6.2438-2444.2005 · DOI
  51. Nibbering, 2004, 99mTc-labeled UBI 29–41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus, J. Nucl. Med., 45, 321
  52. Dijkshoorn, 2004, The synthetic N-terminal peptide of human lactoferrin, hLF(1–11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii, Antimicrob. Agents Chemother., 48, 4919, 10.1128/AAC.48.12.4919-4921.2004 · DOI
  53. Brouwer, 2008, Various routes of administration of 99mTc-labeled synthetic lactoferrin antimicrobial peptide hLF 1–11 enables monitoring and effective killing of multidrug-resistant Staphylococcus aureus infections in mice, Peptides, 29, 1109, 10.1016/j.peptides.2008.03.003 · DOI
  54. Van der Velden, W.J., van Iersel, T.M., Blijlevens, N.M., and Donnelly, J.P. (2009). Safety and tolerability of the antimicrobial peptide human lactoferrin 1–11 (hLF1–11). BMC Med., 7. · DOI
  55. Bellamy, 1992, Identification of the bactericidal domain of lactoferrin, Biochim. Biophys. Acta (BBA) Protein Struct. Mol., 1121, 130
  56. Vorland, 1998, Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin, Scand. J. Infect. Dis., 30, 513, 10.1080/00365549850161557 · DOI
  57. Hunter, 2005, Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent, Antimicrob. Agents Chemother., 49, 3387, 10.1128/AAC.49.8.3387-3395.2005 · DOI
  58. Epand, 1999, Diversity of antimicrobial peptides and their mechanisms of action, Biochim. Biophys. Acta Biomembr., 1462, 11, 10.1016/S0005-2736(99)00198-4 · DOI · Paper page
  59. Gifford, 2005, Lactoferricin: A lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties, Cell. Mol. Life Sci., 62, 2588, 10.1007/s00018-005-5373-z · DOI · Paper page
  60. Silva, 2014, Killing of Mycobacterium avium by Lactoferricin peptides: Improved activity of arginine- and d-amino-acid-containing molecules, Antimicrob. Agents Chemother., 58, 3461, 10.1128/AAC.02728-13 · DOI
  61. Bellamy, 1992, Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin, J. Appl. Bacteriol., 73, 472, 10.1111/j.1365-2672.1992.tb05007.x · DOI · Paper page
  62. Ulvatne, 2001, Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes, FEBS Lett., 492, 62, 10.1016/S0014-5793(01)02233-5 · DOI
  63. Kang, 1996, Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin, Int. J. Pept. Protein Res., 48, 357, 10.1111/j.1399-3011.1996.tb00852.x · DOI
  64. Rekdal, 2002, The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin, J. Pept. Sci., 8, 36, 10.1002/psc.365 · doi:10.1002/psc.365
  65. Rekdal, 2002, Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity, Biochem. Cell Biol., 80, 65, 10.1139/o01-236 · DOI
  66. Liu, 2011, Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides, BioMetals, 24, 1069, 10.1007/s10534-011-9465-y · doi:10.1007/s10534-011-9465-y
  67. Tu, Y.H., Ho, Y.H., Chuang, Y.C., Chen, P.C., and Chen, C.S. (2011). Identification of lactoferricin B intracellular targets using an Escherichia coli proteome chip. PLoS ONE, 6. · DOI
  68. Ho, Y.H., Sung, T.C., and Chen, C.S. (2012). Lactoferricin B inhibits the phosphorylation of the two-component system response regulators BasR and CreB. Mol. Cell. Proteom., 11. · DOI
  69. Shinoda, 1996, Effects of Lactoferrin and Lactoferricin® on the Release of Interleukin 8 from Human Polymorphonuclear Leukocytes, Biosci. Biotechnol. Biochem., 60, 521, 10.1271/bbb.60.521 · DOI
  70. Samuelsen, 2004, Anti-complement effects of lactoferrin-derived peptides, FEMS Immunol. Med. Microbiol., 41, 141, 10.1016/j.femsim.2004.02.006 · DOI
  71. Kuwata, 1998, Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin, Biochim. Biophys. Acta Protein Struct. Mol. Enzymol., 1429, 129, 10.1016/S0167-4838(98)00224-6 · DOI · Paper page
  72. Wakabayashi, 1999, N-acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity, Antimicrob. Agents Chemother., 43, 1267, 10.1128/AAC.43.5.1267 · DOI
  73. Zweytick, 2006, Influence of N-acylation of a peptide derived from human lactoferricin on membrane selectivity, Biochim. Biophys. Acta (BBA) Biomembr., 1758, 1426, 10.1016/j.bbamem.2006.02.032 · DOI
  74. Bellamy, 1993, Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin, Med. Microbiol. Immunol., 182, 97, 10.1007/BF00189377 · DOI · Paper page
  75. Nazmi, 2005, Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli, Peptides, 26, 1537, 10.1016/j.peptides.2005.02.011 · DOI
  76. Wakabayashi, 1998, Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds, Antimicrob. Agents Chemother., 42, 1587, 10.1128/AAC.42.7.1587 · DOI
  77. Vorland, 1999, Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus, Scand. J. Infect. Dis., 31, 173, 10.1080/003655499750006236 · DOI
  78. Oo, 2010, Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection, J. Antimicrob. Chemother., 65, 1243, 10.1093/jac/dkq106 · DOI
  79. Longhi, 2009, Effect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli, J. Antibiot., 62, 109, 10.1038/ja.2008.22 · DOI
  80. Wakabayashi, 2002, Increased Staphylococcus-killing activity of an antimicrobial peptide, lactoferricin B, with minocycline and monoacylglycerol, Biosci. Biotechnol. Biochem., 66, 2161, 10.1271/bbb.66.2161 · doi:10.1271/bbb.66.2161
  81. 2006, Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica, Biochem. Cell Biol., 84, 327
  82. Pellegrini, 2008, Synergistic effect between different milk-derived peptides and proteins, J. Dairy Sci., 91, 2184, 10.3168/jds.2007-0037 · DOI
  83. Nazmi, 2010, Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli, Biometals, 23, 569, 10.1007/s10534-010-9306-4 · DOI
  84. Murata, 2013, Identification of milk proteins enhancing the antimicrobial activity of lactoferrin and lactoferricin, J. Dairy Sci., 96, 4891, 10.3168/jds.2013-6612 · DOI
  85. Turchany, 1995, Giardicidal activity of lactoferrin and N-terminal peptides, Infect. Immun., 63, 4550, 10.1128/iai.63.11.4550-4552.1995 · DOI
  86. Tanaka, 1995, Toxoplasma gondii: Parasiticidal effects of bovine lactoferricin against parasites, Exp. Parasitol., 81, 614, 10.1006/expr.1995.1157 · DOI
  87. Isamida, 1998, Protective effect of lactoferricin against Toxoplasma gondii infection in mice, J. Vet. Med. Sci., 60, 241, 10.1292/jvms.60.241 · DOI
  88. Sengupta, 2012, Effects of lactoferricin B against keratitis-associated fungal biofilms, J. Infect. Chemother., 18, 698, 10.1007/s10156-012-0398-3 · DOI
  89. Yan, 2013, Bovine lactoferricin is anti-inflammatory and anti-catabolic in human articular cartilage and synovium, J. Cell. Physiol., 228, 447, 10.1002/jcp.24151 · doi:10.1002/jcp.24151
  90. Teraguchi, 1994, The bacteriostatic effects of orally administered bovine lactoferrin on intestinal Enterobacteriaceae of SPF mice fed bovine milk, Biosci. Biotechnol. Biochem., 58, 482, 10.1271/bbb.58.482 · doi:10.1271/bbb.58.482
  91. Teraguchi, 1995, Bacteriostatic effect of orally administered bovine lactoferrin on proliferation of Clostridium species in the gut of mice fed bovine milk, Appl. Environ. Microbiol., 61, 501, 10.1128/aem.61.2.501-506.1995 · DOI
  92. Wakabayashi, 2000, Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models, J. Antimicrob. Chemother., 46, 595, 10.1093/jac/46.4.595 · DOI
  93. Lacasse, 2008, Utilization of lactoferrin to fight antibiotic-resistant mammary gland pathogens, J. Anim. Sci., 86, 66, 10.2527/jas.2007-0216 · DOI
  94. Kawai, 2003, Effect of infusing lactoferrin hydrolysate into bovine mammary glands with subclinical mastitis, Vet. Res. Commun., 27, 539, 10.1023/A:1026039522286 · DOI
  95. Kawai, 2007, Antibacterial activity of bovine lactoferrin hydrolysate against mastitis pathogens and its effect on superoxide production of bovine neutrophils, Zoonoses Public Health, 54, 160, 10.1111/j.1863-2378.2007.01031.x · DOI
  96. Zhang, 2007, Mammary gland expression of antibacterial peptide genes to inhibit bacterial pathogens causing mastitis, J. Dairy Sci., 90, 5218, 10.3168/jds.2007-0301 · DOI
  97. Tang, 2011, Dietary bovine lactoferricin improved gut microflora, benefited intestinal mucosal morphology and inhibited circular cytokines delivery in 21-day weaned piglets, J. Appl. Anim. Res., 39, 153, 10.1080/09712119.2011.565570 · DOI
  98. Tang, 2009, Effects of dietary supplementation with an expressed fusion peptide bovine lactoferricin-lactoferrampin on performance, immune function and intestinal mucosal morphology in piglets weaned at age 21 d, Br. J. Nutr., 101, 998, 10.1017/S0007114508055633 · DOI · Paper page
  99. Tang, 2012, Dietary supplementation with bovine lactoferrampin-lactoferricin produced by Pichia pastoris fed-batch fermentation affects intestinal microflora in weaned piglets, Appl. Biochem. Biotechnol., 168, 887, 10.1007/s12010-012-9827-0 · DOI
  100. Tang, 2012, Dietary supplementation with recombinant lactoferrampin-lactoferricin improves growth performance and affects serum parameters in piglets, J. Anim. Vet. Adv., 11, 2548, 10.3923/javaa.2012.2548.2555 · doi:10.3923/javaa.2012.2548.2555
  101. Hou, 2011, Effects of lactoferricin B and cecropin P1 on growth performance, faecal score and dry matter in weaned piglets orally challenged with enterotoxigenic Escherichia coli F4, J. Food Agric. Environ., 9, 275
  102. Vercelli, 2015, Use of lactoferricin, verbascoside and glycerophosphoinositol emulsion in otitis externa treatment: A pilot study, Veterinaria, 29, 49
  103. Quintieri, 2012, Antimicrobial efficacy of pepsin-digested bovine lactoferrin on spoilage bacteria contaminating traditional Mozzarella cheese, Food Microbiol., 31, 64, 10.1016/j.fm.2012.02.015 · doi:10.1016/j.fm.2012.02.015
  104. Caputo, 2015, Pepsin-digested bovine lactoferrin prevents Mozzarella cheese blue discoloration caused by Pseudomonas fluorescens, Food Microbiol., 46, 15, 10.1016/j.fm.2014.06.021 · doi:10.1016/j.fm.2014.06.021
  105. Paul, 2010, Hydrolytic breakdown of lactoferricin by lactic acid bacteria, J. Ind. Microbiol. Biotechnol., 37, 173, 10.1007/s10295-009-0660-6 · DOI
  106. Enrique, 2009, Selectivity and antimicrobial action of bovine lactoferrin derived peptides against wine lactic acid bacteria, Food Microbiol., 26, 340, 10.1016/j.fm.2008.11.003 · DOI
  107. Marcos, 2006, Activity and mode of action against fungal phytopathogens of bovine lactoferricin-derived peptides, J. Appl. Microbiol., 101, 1199, 10.1111/j.1365-2672.2006.03089.x · DOI
  108. Baruzzi, 2015, Efficacy of lactoferricin B in controlling ready-to-eat vegetable spoilage caused by Pseudomonas spp., Int. J. Food Microbiol., 215, 179, 10.1016/j.ijfoodmicro.2015.09.017 · DOI
  109. Venkitanarayanan, 1999, Antibacterial effect of lactoferricin B on Escherichia coli O157:H7 in ground beef, J. Food Prot., 62, 747, 10.4315/0362-028X-62.7.747 · doi:10.4315/0362-028x-62.7.747
  110. Murdock, 2010, The pepsin hydrolysate of bovine lactoferrin causes a collapse of the membrane potential in Escherichia coli O157:H7, Probiot. Antimicrob. Proteins, 2, 112, 10.1007/s12602-010-9039-2 · DOI
  111. Ransom, 2003, Comparison of intervention technologies for reducing Escherichia coli O157:H7 on beef cuts and trimmings, Food Prot. Trends, 23, 24
  112. Calzada, 2012, Effect of lactoferrin and its derivatives against gram-positive bacteria in vitro and, combined with high pressure, in chicken breast fillets, Meat Sci., 90, 71, 10.1016/j.meatsci.2011.06.003 · DOI
  113. Calzada, 2012, Effect of lactoferrin and its derivatives, high hydrostatic pressure, and their combinations, on Escherichia coli O157:H7 and Pseudomonas fluorescens in chicken filets, Innov. Food Sci. Emerg. Technol., 13, 51, 10.1016/j.ifset.2011.07.016 · DOI
  114. Morales, 2009, Bactericidal activity of lactoferrin and its amidated and pepsin-digested derivatives against Pseudomonas fluorescens in ground beef and meat fractions, J. Food Prot., 72, 760, 10.4315/0362-028X-72.4.760 · DOI
  115. Groenink, 2004, Lactoferrampin: A novel antimicrobial peptide in the N1-domain of bovine lactoferrin, Peptides, 25, 177, 10.1016/j.peptides.2003.12.006 · DOI · Paper page
  116. Haney, 2007, Solution structures and model membrane interactions of lactoferrampin, an antimicrobial peptide derived from bovine lactoferrin, Biochim. Biophys. Acta Biomembr., 1768, 2355, 10.1016/j.bbamem.2007.04.018 · DOI
  117. Rastogi, N., Nagpal, N., Alam, H., Pandey, S., Gautam, L., Sinha, M., Shin, K., Manzoor, N., Virdi, J.S., and Kaur, P. (2014). Preparation and antimicrobial action of three tryptic digested functional molecules of bovine lactoferrin. PLoS ONE, 9. · DOI
  118. Hammami, 2013, Isolation and identification of antimicrobial peptides derived by peptic cleavage of whey protein isolate, J. Funct. Foods, 5, 706, 10.1016/j.jff.2013.01.014 · DOI
  119. Japelj, 2010, Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo, Antimicrob. Agents Chemother., 55, 218
  120. Przysiecka, 2015, Viral and other cell-penetrating peptides as vectors of therapeutic agents in medicine, J. Pharmacol. Exp. Ther., 354, 32, 10.1124/jpet.115.223305 · DOI
  121. Nazmi, 2010, Microbicidal effect of the lactoferrin peptides Lactoferricin17–30, Lactoferrampin265–284, and Lactoferrin chimera on the parasite Entamoeba histolytica, BioMetals, 23, 563, 10.1007/s10534-010-9295-3 · DOI
  122. Vidal, 2014, Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and the decrease in luxS gene expression by lactoferrin, BioMetals, 27, 969, 10.1007/s10534-014-9775-y · DOI
  123. Bolscher, 2012, Chimerization of lactoferricin and lactoferrampin peptides strongly potentiates the killing activity against Candida albicans, Biochem. Cell Biol., 90, 378, 10.1139/o11-085 · DOI

Cited by

See all 236

Metadata

Authors
Bruni, N., Capucchio, M., Biasibetti, E., Pessione, E., Cirrincione, S., Giraudo, L., Corona, A., & Dosio, F.
Venue
Molecules
Publisher
MDPI AG
Published
2016-06-11
Volume
21
Issue
6
Pages
752
ISSN
1420-3049 (ISSN-L)
OpenAlex
W2417653920
Cited by
236
References
7
FWCI
14.71
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.